Biomerica (BMRA) Receivables (2011 - 2026)

Biomerica (BMRA) has 16 years of Receivables data on file, last reported at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 25.07% year-over-year to $1.9 million; the trailing twelve-month figure through Feb 2026 stood at $1.9 million (down 25.07% YoY), and the FY2025 full-year result was $1.5 million, down 22.22% from the prior year.
• Receivables slipped to $1.9 million in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $3.1 million in Q3 2024 to a low of $772000.0 in Q1 2023.
• A 5-year average of $2.0 million and a median of $1.9 million in 2026 frame the typical range for Receivables.
• Across the five-year window, Receivables plunged 54.6% in 2022 and soared 195.73% in 2024, its largest moves.
• Tracing BMRA's Receivables over 5 years: stood at $1.4 million in 2022, then jumped by 57.14% to $2.2 million in 2023, then increased by 24.26% to $2.7 million in 2024, then fell by 25.72% to $2.0 million in 2025, then fell by 3.57% to $1.9 million in 2026.
• Business Quant data shows BMRA's Receivables at $1.9 million in Q1 2026, $2.0 million in Q4 2025, and $2.5 million in Q3 2025.